<DOC>
	<DOCNO>NCT03097861</DOCNO>
	<brief_summary>To evaluate bioequivalence sprinkle capsule formulation lubiprostone , compare placebo , administer orally subject CIC .</brief_summary>
	<brief_title>Evaluation Bioequivalence Sprinkle Capsule Formulations Lubiprostone , Compared Placebo</brief_title>
	<detailed_description />
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Lubiprostone</mesh_term>
	<criteria>Subject either medicallyconfirmed diagnosis chronic constipation ( per Rome III ) , meet diagnosis confirm use Rome III constipation module questionnaire Screening period . Subject male female , 18 old year age Subject must stable dose fiber supplement concomitant medication indication lower blood pressure Subject gastrointestinal ( GI ) condition , constipation , affect GI motility defecation . Subject unable eat drink , take oral medication , hold oral medication due vomit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>